Doing things out of proper sequence can require a do-over.  But in law, as elsewhere, the do-over may come too late. 

Just ask Abraxis, a drug maker that today lost a lawsuit because the company it bought patents from didn't own them at the time.

Abraxis signed an Asset Purchase Agreement with AstraZeneca in April 2006. 

Russian scientists come up with a way to make an ozone-friendly agent that helps prepare materials useful in making units that store hot or cold.  They tell the American company that hired them about the results of their study.  And the U.S. firm starts using the process that their Russian colleagues discovered.

Does the U.S. outfit qualify

Blawgletter recalls early on hearing about "the bow tie rule".  People who wear bow ties, the rule supposes, want to stand out.  They regard themselves as unique.  They desire others to see visible proof of their disdain for norms, wardrobe-wise and otherwise.  And you don't want them on your jury.  They'll tend to disagree with other

The Federal Circuit today tossed the work of a jury on grounds that the losing parties never raised before their appeal.  "Plain error", the panel held.

Uh.

The plaintiff, WordTech Systems, alleged that Integrated Network Systems, and two men who worked at INS, infringed patents relating to robo-copying compact disks.  At trial, the district court

Rube Goldberg Flyswatter
Flyswatter by Rube Goldberg.

You've heard about the genius whose incandescent idea for a new contraption wakes him in the hours before sunup.  You'll also recall Edison's cutesy statement that "[g]enius is one percent inspiration, ninety-nine percent perspiration."

Both the burning thought that disturbs the inventor's slumber and the drudgery that produces the pre-dawn